✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Magnesium sulfateis the generic ingredient in ten branded drugs marketed by B Braun Medical Inc, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, Mylan Labs Ltd, Gland Pharma Ltd, Milla Pharms, Exela Pharma, Braintree Labs, Baxter Hlthcare, Gator Pharms, and Novel Labs Inc, and is included in twenty-five NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.
There are nine drug master file entries for magnesium sulfate. Seventeen suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for magnesium sulfate
|Drug Master File Entries:||9|
|Finished Product Suppliers / Packagers:||17|
|Raw Ingredient (Bulk) Api Vendors:||129|
|Formulation / Manufacturing:||see details|
|What excipients (inactive ingredients) are in magnesium sulfate?||magnesium sulfate excipients list|
|DailyMed Link:||magnesium sulfate at DailyMed|
Recent Clinical Trials for magnesium sulfate
Identify potential brand extensions & 505(b)(2) entrants
|Aalborg University Hospital||Phase 4|
|Konya Meram State Hospital||N/A|
|Litholink Corp||Early Phase 1|
Generic filers with tentative approvals for MAGNESIUM SULFATE
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.